Julio Montaner
#53,722
Most Influential Person Now
HIV/AIDS researcher
Julio Montaner's AcademicInfluence.com Rankings
Julio Montanermedical Degrees
Medical
#579
World Rank
#780
Historical Rank
Epidemiology
#864
World Rank
#900
Historical Rank
Julio Montanerphilosophy Degrees
Philosophy
#12409
World Rank
#17225
Historical Rank
Logic
#9257
World Rank
#11712
Historical Rank
Download Badge
Medical Philosophy
Julio Montaner's Degrees
- Doctorate Medicine University of Buenos Aires
- Masters Epidemiology University of British Columbia
- PhD Epidemiology University of British Columbia
Why Is Julio Montaner Influential?
(Suggest an Edit or Addition)According to Wikipedia, Julio S. G. Montaner, is an Argentine-Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART , a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.
Julio Montaner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Needle exchange is not enough: lessons from the Vancouver injecting drug use study (1997) (654)
- Suppression of plasma viral load below 20 copies/ml is required to achieve a long‐term response to therapy (1998) (264)
- Effect of drug law enforcement on drug market violence: a systematic review. (2011) (223)
- Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. (2005) (207)
- Income generating activities of people who inject drugs. (2007) (153)
- Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study (2016) (144)
- Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs (2009) (141)
- Social and structural determinants of HAART access and adherence among injection drug users. (2010) (137)
- Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. (2008) (136)
- The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. (2014) (121)
- CD4+ T-Cell Count Monitoring Does Not Accurately Identify HIV-Infected Adults With Virologic Failure Receiving Antiretroviral Therapy (2008) (118)
- Injection drug use cessation and use of North America's first medically supervised safer injecting facility. (2011) (116)
- Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. (2006) (115)
- Lower socioeconomic status and shorter survival following HIV infection (1994) (110)
- Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting. (2013) (88)
- Depressive Symptoms Decline Among Persons on HIV Protease Inhibitors (2000) (84)
- Drug-related overdoses within a medically supervised safer injection facility (2006) (81)
- Drug-related overdoses within a medically supervised safer injection facility (2006) (81)
- Vienna Declaration: a call for evidence-based drug policies (2010) (80)
- Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review (2012) (76)
- Incarceration and drug use patterns among a cohort of injection drug users. (2009) (73)
- Modelling crack cocaine use trends over 10 years in a Canadian setting. (2010) (70)
- Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. (2008) (70)
- Characteristics of Injection Drug Users Who Participate in Drug Dealing: Implications for Drug Policy (2008) (69)
- Antiretroviral medication use among injection drug users: two potential futures (2000) (63)
- Factors Associated with Public Injecting Among Users of Vancouver's Supervised Injection Facility (2007) (61)
- The temporal relationship between drug supply indicators: an audit of international government surveillance systems (2013) (61)
- Early Sex Work Initiation Independently Elevates Odds of HIV Infection and Police Arrest Among Adult Sex Workers in a Canadian Setting (2014) (58)
- Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. (2009) (55)
- Safer injecting education for HIV prevention within a medically supervised safer injecting facility (2005) (52)
- Interest in low-threshold employment among people who inject illicit drugs: implications for street disorder. (2011) (51)
- Denial of prescription analgesia among people who inject drugs in a Canadian setting. (2015) (49)
- Inability to Access Addiction Treatment and Risk of HIV Infection Among Injection Drug Users (2004) (47)
- Randomized, Controlled Study of the Effects of a Short Course of Prednisone on the Incidence of Rash Associated With Nevirapine in Patients Infected With HIV‐1 (2003) (47)
- HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. (2008) (46)
- Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting (2013) (45)
- High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. (2015) (45)
- Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes. (2007) (45)
- Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting (2016) (44)
- Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016. (2018) (44)
- Lopinavir/Ritonavir Plus Nevirapine as a Nucleoside-Sparing Approach in Antiretroviral-Experienced Patients (NEKA Study) (2005) (42)
- Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012 (2014) (42)
- Self-management of pain among people who inject drugs in Vancouver. (2014) (41)
- Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting. (2013) (39)
- The Impact of Disease Stage on Direct Medical Costs of HIV Management (2012) (32)
- The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. (2015) (31)
- Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. (2006) (31)
- Effect of Methadone Treatment on Incarceration Rates among Injection Drug Users (2008) (30)
- Drug treatment courts in Canada: an evidence-based review. (2007) (28)
- The Validity of Reporting Willingness to Use a Supervised Injecting Facility on Subsequent Program Use among People Who Use Injection Drugs (2012) (26)
- Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs. (2015) (25)
- Long-term non-progression in HIV infection (1995) (22)
- Higher Rate of Toxicity With No Increased Efficacy When Hydroxyurea Is Added to a Regimen of Stavudine Plus Didanosine and Nevirapine in Primary HIV Infection (2002) (22)
- Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. (2012) (22)
- Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. (2002) (22)
- Validity of Self-Reported Adherence Among Injection Drug Users (2008) (21)
- The impact of childhood emotional abuse on violence among people who inject drugs. (2015) (20)
- Expanded HAART Coverage is Associated with Decreased Population-level HIV-1-RNA and Annual New HIV Diagnoses in British Columbia, Canada (2011) (19)
- Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis. (2017) (19)
- Prescription opioid use and non-fatal overdose in a cohort of injection drug users (2015) (19)
- Factors associated with difficulty accessing crack cocaine pipes in a Canadian setting. (2012) (19)
- A Dose-Dependent Relationship between Exposure to a Street-Based Drug Scene and Health-Related Harms among People Who Use Injection Drugs (2011) (19)
- Methadone use among HIV-positive injection drug users in a Canadian setting. (2010) (17)
- The impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugs. (2014) (16)
- Elevated rates of antiretroviral treatment discontinuation among HIV-infected injection drug users: implications for drug policy and public health (2004) (16)
- Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. (2016) (16)
- Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics. (2012) (16)
- Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users. (2006) (14)
- High Prevalence of Assisted Injection Among Street-Involved Youth in a Canadian Setting (2016) (13)
- Non-medical prescription opioid use predicts injection initiation among street-involved youth. (2016) (13)
- The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users (2004) (13)
- Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. (2013) (13)
- Crystal methamphetamine initiation among street-involved youth (2014) (12)
- Alternation of Antiretroviral Drug Regimens for HIV Infection. Efficacy, Safety and Tolerability at Week 96 of the Swatch Study (2004) (12)
- Total lymphocyte counts and ART in resource-limited settings (2005) (11)
- INFLUENCE OF ZIDOVUDINE ON PROGRESSION TO AIDS IN COHORT STUDIES (1989) (11)
- Socializing in an open drug scene: the relationship between access to private space and drug-related street disorder. (2012) (11)
- Concorde trial of immediate versus deferred zidovudine (1994) (10)
- Universal Access in the Fight Against HIV/AIDS (2010) (9)
- Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification (2012) (8)
- Prevalence and correlates of cervical cancer screening among injection drug users. (2006) (8)
- Aetiology of AIDS (1993) (7)
- Drug dealing cessation among a cohort of drug users in Vancouver, Canada. (2011) (7)
- Implications of the Henan Province report on the treatment as prevention debate. (2011) (7)
- A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients. (2009) (7)
- Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review (2019) (6)
- Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting. (2017) (6)
- Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996–2014: A Prospective Cohort Study (2017) (6)
- Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavir. (2005) (6)
- Exploring disparities between global HIV/AIDS funding and recent tsunami relief efforts: an ethical analysis. (2007) (6)
- Consecuencias nefastas para la epidemia de virus de la inmunodeficiencia humana en España a raíz del nuevo marco legal sanitario sobre los inmigrantes en situación irregular: ahorra hoy y pagarás mañana (2012) (6)
- A call to reprioritise metrics to evaluate illicit drug policy (2016) (5)
- Continuing professional development in HIV chronic disease management for primary care providers (2015) (3)
- Cautious optimism over new anti-HIV agents (1995) (3)
- Hepatitis C testing in Canada: don’t leave baby boomers behind (2017) (3)
- Ethical and scientific issues surrounding solid organ transplantation in HIV-positive patients: Absence of evidence is not evidence of absence. (2006) (3)
- Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada (2019) (2)
- New international AIDS organisation (1994) (1)
- Nevirapina: el primer inhibidor no nucleósido de la transcriptasa inversa (1998) (1)
- Treatment of Multiple Drug-Resistant Tuberculosis in Patients With the Acquired Immunodeficiency Syndrome (1998) (0)
- A Made in Canada Strategy to Stop HIV and AIDS (2010) (0)
- Ampliar el acceso a la terapia antirretrovírica en tiempos de restricciones económicas. (2010) (0)
- Treinta años después: amplia cobertura con HAART, la clave para el control global del VIH y el sida (2011) (0)
- Tratamiento antirretrovírico: estado actual y nuevas tendencias (1995) (0)
- Induction–maintenance antiretroviral therapy (1998) (0)
This paper list is powered by the following services:
Other Resources About Julio Montaner
What Schools Are Affiliated With Julio Montaner?
Julio Montaner is affiliated with the following schools:
